The Trump administration has canceled an important federal vaccine advisory committee meeting initially set for March, critical for selecting influenza vaccine strains for the upcoming winter. This marks the second cancellation since Robert F. Kennedy Jr. became health and human services secretary, raising alarms about the impact on public health protocols. The advisory meetings, usually facilitated by the FDA, involve expert discussions on flu strain selection influenced by WHO recommendations. Experts are questioning the implications of these cancellations on seasonal vaccine efficacy and public trust in vaccination efforts.
The cancellation of the federal vaccine advisory committee meeting intended for the influenza vaccine selection raises concerns about the future of public health decision-making.
The postponement signals potential disruptions in the annual flu vaccine selection process, which relies on timely expert discussions and data sharing.
Collection
[
|
...
]